Personnel Information

写真a

Fujiwara Motohiro


Job title

Graduate Student
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2016.02
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Urology， Senior Resident
  • 2021.04
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Systemic Organ Regulation， Department of Urology， Graduate Student
  • 2021.04
    -
    Now
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Urology， Graduate Student
To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Motohiro Fujiwara, Minato Yokoyama, Masahiro Toide, Ryo Fujiwara, Hajime Tanaka, Tomohiko Oguchi, Yoshinobu Komai, Soichiro Yoshida, Yoh Matsuoka, Noboru Numao, Shinya Yamamoto, Iwao Fukui, Junji Yonese, Yasuhisa Fujii. Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study. Jpn J Clin Oncol. 2023.03; 53 (3): 263-269. ( PubMed, DOI )

  2. Yuki Nakamura, Hiroshi Fukushima, Kasumi Yoshitomi, Takahiko Soma, Masaki Kobayashi, Bo Fan, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Minato Yokoyama, Yasuhisa Fujii. Significance of dorsal bladder neck involvement in predicting the progression of non-muscle-invasive bladder cancer. Int J Urol. 2022.12; ( PubMed, DOI )

  3. Ryo Fujiwara, Takeshi Yuasa, Shinya Yamamoto, Motohiro Fujiwara, Kosuke Takemura, Tetsuya Urasaki, Ryosuke Oki, Yoshinobu Komai, Tomohiko Oguchi, Noboru Numao, Junji Yonese. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab. Nutr Cancer. 2022.11; 1-8. ( PubMed, DOI )

  4. Eri Fukagawa, Takeshi Yuasa, Kentaro Inamura, Kosuke Hamada, Motohiro Fujiwara, Yoshinobu Komai, Junji Yonese. large-cell neuroendocrine carcinoma of the prostate: A case report and literature review. IJU Case Rep. 2022.11; 5 (6): 505-510. ( PubMed, DOI )

  5. Yuki Arita, Soichiro Yoshida, Keisuke Shigeta, Thomas C Kwee, Hiromi Edo, Naoko Okawara, Masahiro Hashimoto, Ryota Ishii, Ryo Ueda, Shuji Mikami, Motohiro Fujiwara, Yuma Waseda, Eiji Kikuchi, Yasuhisa Fujii, Masahiro Jinzaki. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Eur Urol Oncol. 2022.08; ( PubMed, DOI )

  6. Kasumi Kaneko Yoshitomi, Yoshinobu Komai, Tatsuya Yamamoto, Eri Fukagawa, Kosuke Hamada, Yusuke Yoneoka, Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Noboru Numao, Takeshi Yuasa, Shinya Yamamoto, Iwao Fukui, Junji Yonese. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging. Urology. 2022.06; 164 286-292. ( PubMed, DOI )

  7. Yoshitomi KK, Komai Y, Yamamoto T, Fukagawa E, Hamada K, Yoneoka Y, Fujiwara M, Fujiwara R, Oguchi T, Numao N, Yuasa T, Yamamoto S, Fukui I, Yonese J. Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score With 3D Reconstructed Virtual Imaging Urology. 2022.06;

  8. Motohiro Fujiwara, Noboru Numao, Shinya Yamamoto, Yudai Ishikawa, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Yoh Matsuoka, Takeshi Yuasa, Junji Yonese. Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side-specific negative lymph node metastasis at radical prostatectomy. Prostate. 2022.06; 82 (8): 904-910. ( PubMed, DOI )

  9. Motohiro Fujiwara, Ryo Fujiwara, Tetsuya Urasaki, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Shinya Yamamoto, Junji Yonese, Takeshi Yuasa. Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer. Anticancer Res. 2022.04; 42 (4): 2045-2051. ( PubMed, DOI )

  10. Motohiro Fujiwara, Ryo Fujiwara, Tomohiko Oguchi, Yoshinobu Komai, Noboru Numao, Shinya Yamamoto, Junji Yonese, Takeshi Yuasa. Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy. Anticancer Res. 2022.04; 42 (4): 2123-2130. ( PubMed, DOI )

  11. Yoshida S, Takahara T, Arita Y, Toda K, Kimura K, Fujiwara M, Tanaka H, Yokoyama M, Matsuoka Y, Yoshimura R, Fujii Y.. Patterns of recurrence in genuine and induced oligometastatic castration-resistant prostate cancer treated with progressive site-directed therapy. Int J Urol. 2022;

  12. Motohiro Fujiwara, Hajime Tanaka, Takeshi Yuasa, Yoshinobu Komai, Tomohiko Oguchi, Ryo Fujiwara, Noboru Numao, Shinya Yamamoto, Yasuhisa Fujii, Iwao Fukui, Junji Yonese. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice. Int J Urol. 2021.09; 28 (9): 920-926. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using 8uorescence cystoscopy with orally administered 5-aminolevulinic acid. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  2. Y. Ishikawa, S. Uehara, K. Ishihara, K. Hirose, T. Soma, M. Fujiwara, M. Kobayashi, B. Fan, Y. Nakamura, Y. Uchida, S. Fukuda, H. Tanaka, S. Yoshida, M. Yokoyama, Y. Matsuoka, Y. Fujii. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. 37th Annual EAU Congress 2022 European Association of Urology 2022.07.01

  3. Ishikawa Y, Sho U, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Orally administered 5-aminolevulinic acid can cause intraoperative hypotension in patients with bladder cancer undergoing transurethral resection. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  4. Ishikawa Y, Uehara S, Ishihara K, Hirose K, Soma T, Fujiwara M, Kobayashi M, Fan B, Nakamura Y, Uchida Y, Fukuda S, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujii Y. Variability in diagnostic performance of non-muscle invasive bladder cancer for each region using fluorescence cystoscopy with orally administered 5-aminolevulinic acid. the 37th Annual European Association of Urology(EAU) Congress 2022.07

  5. Fujiwara M et al.. Feasibility of non-use of antimicrobial prophylaxis in minimally invasive. 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.07 San diego, USA

  6. Numao N et al. Optimal combination of MRI-targeted biopsy and systematic biopsy for men with suspicion of prostate cancer. . 米国泌尿器科学会（annual meeting of the American Urological Association） 2016.05.06 San diego, USA

  7. Fujiwara M et al.. Antibiotic prophylaxis is avoidable in minimally invasive clean surgery for renal or adrenal tumors: A prospective study of 678 cases. Munich, Germany 2016.03.12 Munich, Germany

▼display all

To the head of this page.▲